| NCT07102381 | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer | RECRUITING | PHASE2 | 2025-09-24 | 2030-08-01 | 2028-01-01 |
| NCT06961266 | A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 | RECRUITING | PHASE1 | 2025-05-13 | 2026-04-01 | 2026-04-01 |
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | RECRUITING | PHASE2 | 2025-01-14 | 2027-12-31 | 2026-12-31 |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer | RECRUITING | PHASE3 | 2024-08-13 | 2031-11-26 | 2028-09-26 |
| NCT06282575 | Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer | RECRUITING | PHASE3 | 2024-07-19 | 2030-04-01 | 2028-12-01 |
| NCT06108050 | JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors | RECRUITING | PHASE1 | 2023-11-07 | 2028-05-31 | 2027-11-30 |
| NCT05875974 | A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy | COMPLETED | PHASE4 | 2023-07-27 | 2025-03-13 | 2025-03-13 |
| NCT05733390 | A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder | WITHDRAWN | PHASE2 | 2023-06-30 | 2023-11-09 | 2023-11-09 |
| NCT05864846 | A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | ACTIVE_NOT_RECRUITING | PHASE4 | 2023-06-29 | 2026-03-26 | 2026-03-26 |
| NCT05869773 | A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy | COMPLETED | PHASE4 | 2023-06-26 | 2025-03-10 | 2025-02-25 |
| NCT05734066 | Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma | RECRUITING | PHASE1, PHASE2 | 2023-05-23 | 2027-06-01 | 2026-12-01 |
| NCT05720494 | A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants | COMPLETED | PHASE1 | 2023-01-26 | 2023-09-29 | 2023-09-29 |
| NCT05580562 | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | RECRUITING | PHASE3 | 2023-01-23 | 2026-08 | 2026-08 |
| NCT05631327 | A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors | TERMINATED | PHASE1 | 2022-12-19 | 2024-04-24 | 2024-04-24 |
| NCT05642442 | A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease | COMPLETED | PHASE2 | 2022-12-01 | 2024-11-11 | 2024-10-23 |
| NCT05651152 | A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants | COMPLETED | PHASE1 | 2022-11-28 | 2023-11-15 | 2023-11-15 |
| NCT05288283 | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures | TERMINATED | PHASE3 | 2022-10-31 | 2023-09-28 | 2023-09-28 |
| NCT05557045 | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 | RECRUITING | PHASE1 | 2022-10-10 | 2028-04-01 | 2028-04-01 |
| NCT05126433 | Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors | TERMINATED | PHASE2 | 2022-03-03 | 2023-12-20 | 2023-12-20 |
| NCT05178316 | A Study of JZP150 in Adults With Posttraumatic Stress Disorder | COMPLETED | PHASE2 | 2021-12-29 | 2023-12-05 | 2023-12-05 |
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | COMPLETED | PHASE2 | 2021-12-06 | 2024-05-30 | 2024-05-30 |
| NCT05152147 | A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-12-02 | 2026-05-15 | 2025-10-15 |
| NCT05027139 | A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-09-15 | 2025-09-26 | 2025-09-26 |
| NCT04984278 | Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis | TERMINATED | PHASE3 | 2021-08-16 | 2022-11-11 | 2022-11-11 |
| NCT05044819 | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | ACTIVE_NOT_RECRUITING | PHASE4 | 2021-07-07 | 2028-03-31 | 2027-08-01 |
| NCT04745026 | Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder | COMPLETED | PHASE2 | 2021-05-31 | 2023-12-21 | 2023-12-21 |
| NCT04485104 | Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | TERMINATED | PHASE3 | 2021-05-19 | 2025-01-28 | 2025-01-28 |
| NCT04571645 | Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia | TERMINATED | PHASE3 | 2021-04-30 | 2022-05-16 | 2022-05-16 |
| NCT04794491 | An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy | COMPLETED | PHASE4 | 2021-03-22 | 2022-11-15 | 2022-11-15 |
| NCT04592159 | Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | WITHDRAWN | PHASE2, PHASE3 | 2021-02-01 | 2023-03 | 2023-03 |
| NCT04657666 | Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis | COMPLETED | PHASE3 | 2020-12-21 | 2022-05-10 | 2022-05-04 |
| NCT04541082 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | RECRUITING | PHASE1 | 2020-10-26 | 2026-12 | 2025-12 |
| NCT04466891 | A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers | COMPLETED | PHASE2 | 2020-10-01 | 2024-07-11 | 2023-07-28 |
| NCT04203498 | Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis | TERMINATED | PHASE3 | 2020-10-01 | 2023-02-28 | 2023-02-10 |
| NCT04133480 | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution | WITHDRAWN | PHASE4 | 2020-10 | 2021-12 | 2021-12 |
| NCT04421456 | Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment | TERMINATED | PHASE2 | 2020-08-18 | 2022-03-16 | 2022-03-16 |
| NCT04389840 | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | TERMINATED | PHASE2, PHASE3 | 2020-07-08 | 2021-05-20 | 2021-05-20 |
| NCT04224272 | A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer | COMPLETED | PHASE2 | 2020-06-10 | 2025-06-30 | 2023-04-28 |
| NCT04252586 | A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | TERMINATED | PHASE3 | 2020-02-28 | 2021-06-09 | 2021-06-09 |
| NCT03849456 | Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder | TERMINATED | PHASE2 | 2020-01-07 | 2020-05-26 | 2020-05-26 |
| NCT04145531 | An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | COMPLETED | PHASE2, PHASE3 | 2019-12-27 | 2022-07-13 | 2022-07-13 |
| NCT04075747 | A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia | COMPLETED | PHASE1 | 2019-12-02 | 2023-09-12 | 2022-02-07 |
| NCT03436953 | A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease | WITHDRAWN | PHASE2 | 2019-12 | 2020-12 | 2020-09 |
| NCT04038437 | A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML | COMPLETED | PHASE1 | 2019-10-15 | 2022-09-24 | 2022-04-26 |
| NCT03954106 | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity | TERMINATED | PHASE2 | 2019-10-04 | 2020-09-30 | 2020-09-18 |
| NCT03929666 | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | COMPLETED | PHASE2 | 2019-08-29 | 2025-08-30 | 2025-08-30 |
| NCT03848832 | Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | TERMINATED | PHASE3 | 2019-07-29 | 2021-01-21 | 2021-01-21 |
| NCT03532035 | Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia | WITHDRAWN | PHASE2 | 2018-12-15 | 2019-05-10 | 2019-05-10 |
| NCT03533114 | A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension | COMPLETED | PHASE3 | 2018-11-27 | 2020-12-18 | 2020-06-12 |
| NCT03555955 | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 | COMPLETED | PHASE1 | 2018-11-20 | 2021-05-26 | 2021-05-26 |
| NCT03485729 | ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer | TERMINATED | PHASE2 | 2018-03-21 | 2023-01-19 | 2023-01-19 |
| NCT03406702 | CX-8998 for Absence Seizures | COMPLETED | PHASE2 | 2018-02-25 | 2019-03-29 | 2019-03-29 |
| NCT03339297 | An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) | COMPLETED | PHASE2 | 2018-02-21 | 2020-05-12 | 2020-05-12 |
| NCT03416530 | ONC201 in Pediatric H3 K27M Gliomas | TERMINATED | PHASE1 | 2018-01-25 | 2023-05-24 | 2022-12-31 |
| NCT03339401 | The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation | TERMINATED | PHASE2 | 2017-12-22 | 2019-05-10 | 2019-05-10 |
| NCT03295396 | ONC201 in Adults With Recurrent H3 K27M-mutant Glioma | TERMINATED | PHASE2 | 2017-10-30 | 2023-07-19 | 2022-12-31 |
| NCT03101241 | A Phase 2 RCT Study of CX-8998 for Essential Tremor | COMPLETED | PHASE2 | 2017-08-29 | 2018-07-16 | 2018-07-16 |
| NCT02954887 | Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) | COMPLETED | PHASE3 | 2017-05-12 | 2019-06-13 | 2019-06-13 |
| NCT02953548 | Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) | COMPLETED | PHASE3 | 2017-04-24 | 2018-05-07 | 2018-05-07 |
| NCT02863991 | Oral ONC201 in Relapsed/Refractory Multiple Myeloma | TERMINATED | PHASE1, PHASE2 | 2017-04-19 | 2019-12-16 | 2019-09-17 |
| NCT03030599 | A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy | COMPLETED | PHASE3 | 2017-03-14 | 2019-07-10 | 2019-01-24 |
| NCT03037203 | A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness | COMPLETED | PHASE2 | 2017-01 | 2018-08 | 2018-08 |
| NCT02607904 | An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | COMPLETED | PHASE2 | 2016-12-15 | 2019-05-27 | 2019-05-27 |
| NCT02607891 | A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | COMPLETED | PHASE2 | 2016-11-09 | 2018-10-02 | 2018-09-11 |
| NCT02892123 | Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers | COMPLETED | PHASE1 | 2016-09-30 | 2024-10-31 | 2024-10-31 |
| NCT02851407 | Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients | COMPLETED | PHASE3 | 2016-09-01 | 2020-10-20 | 2020-10-20 |
| NCT02544750 | An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | COMPLETED | PHASE3 | 2016-08-31 | 2021-06-11 | 2021-06-11 |
| NCT02873338 | Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia | COMPLETED | PHASE2 | 2016-08 | 2019-06 | 2019-06 |
| NCT02806895 | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA | COMPLETED | PHASE2 | 2016-07-05 | 2019-05-28 | 2019-05-28 |
| NCT02806908 | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy | COMPLETED | PHASE2 | 2016-06 | 2019-05-19 | 2019-05-19 |
| NCT02544763 | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | COMPLETED | PHASE3 | 2016-04-06 | 2019-02-26 | 2019-01-22 |
| NCT02564952 | An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | COMPLETED | PHASE2 | 2016-03-11 | 2017-06-07 | 2017-06-07 |
| NCT02365610 | A Study of GWP42006 in People With Focal Seizures - Part B | COMPLETED | PHASE2 | 2016-03 | 2017-09 | 2017-07 |
| NCT02565108 | A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | COMPLETED | PHASE2 | 2016-01-20 | 2016-07-21 | 2016-07-21 |
| NCT02525692 | Oral ONC201 in Adult Recurrent Glioblastoma | TERMINATED | PHASE2 | 2016-01 | 2023-04-17 | 2023-04-17 |
| NCT02439970 | A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease | TERMINATED | PHASE3 | 2015-09 | 2016-01-30 | 2016-01-30 |
| NCT02439957 | A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus | TERMINATED | PHASE3 | 2015-09 | 2016-07-31 | 2016-05-15 |
| NCT02224560 | Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults | COMPLETED | PHASE3 | 2015-06-08 | 2016-05-19 | 2016-05-19 |
| NCT02348619 | "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" | COMPLETED | PHASE3 | 2015-05 | 2016-11 | 2016-11 |
| NCT02348606 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" | COMPLETED | PHASE3 | 2015-05 | 2016-12 | 2016-12 |
| NCT02348593 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" | COMPLETED | PHASE3 | 2015-05 | 2017-02 | 2017-02 |
| NCT02348632 | "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" | COMPLETED | PHASE3 | 2015-05 | 2017-12 | 2017-12 |
| NCT02224690 | A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults | COMPLETED | PHASE3 | 2015-04-28 | 2016-03-18 | 2016-03-18 |
| NCT02224703 | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome | COMPLETED | PHASE3 | 2015-04-13 | 2018-04-09 | 2018-04-09 |
| NCT02269579 | Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment | WITHDRAWN | PHASE2 | 2015-04 | 2017-06 | 2017-06 |
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | COMPLETED | PHASE3 | 2015-03-30 | 2015-11-26 | 2015-11-26 |
| NCT02369471 | A Study of GWP42006 in People With Focal Seizures - Part A | COMPLETED | PHASE2 | 2015-03 | 2015-11 | 2015-10 |
| NCT02325011 | An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. | COMPLETED | PHASE1 | 2014-11 | 2015-02 | 2015-02 |
| NCT02091206 | A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) | COMPLETED | PHASE2 | 2014-10-22 | 2015-03-09 | 2015-03-09 |
| NCT04268966 | An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola | WITHDRAWN | PHASE2 | 2014-10 | 2015-12 | 2015-11 |
| NCT02221869 | A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy | COMPLETED | PHASE3 | 2014-10-01 | 2019-01-25 | 2017-02 |
| NCT02271347 | An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease | WITHDRAWN | PHASE2 | 2014-10 | 2015-01 | 2015-01 |
| NCT01812616 | A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients | COMPLETED | PHASE1, PHASE2 | 2014-09 | 2016-06 | 2016-06 |
| NCT02257684 | A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) | TERMINATED | PHASE2 | 2014-09 | 2016-01 | 2015-02 |
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | COMPLETED | PHASE2 | 2014-07 | 2016-01 | 2015-05 |
| NCT02150928 | An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) | WITHDRAWN | PHASE2 | 2014-05 | | 2015-06 |
| NCT02087306 | Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection | COMPLETED | PHASE3 | 2014-03 | 2016-08 | 2016-06 |
| NCT02006628 | A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder | COMPLETED | PHASE2 | 2014-02-25 | 2015-01-08 | 2015-01-08 |
| NCT02053272 | A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes | COMPLETED | PHASE2 | 2014-02 | 2016-02 | 2016-02 |
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | WITHDRAWN | PHASE1, PHASE2 | 2014-01 | 2016-12 | 2015-12 |
| NCT01898520 | A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years | COMPLETED | PHASE3 | 2013-12 | 2017-03 | 2016-09 |
| NCT02056782 | A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia | COMPLETED | PHASE1 | 2013-12 | 2015-06 | 2015-02 |
| NCT01812603 | A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma | COMPLETED | PHASE1, PHASE2 | 2013-09 | 2016-06 | 2015-01 |
| NCT01918735 | A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects | COMPLETED | PHASE1 | 2013-08 | 2013-12 | 2013-12 |
| NCT01769170 | A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients | COMPLETED | PHASE3 | 2013-08 | 2016-01 | 2015-12 |
| NCT01843634 | Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia | COMPLETED | EARLY_PHASE1 | 2013-08 | 2015-04 | 2015-04 |
| NCT01887301 | Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients | COMPLETED | PHASE1 | 2013-07 | 2014-05 | 2014-05 |
| NCT01696084 | Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia | COMPLETED | PHASE3 | 2012-12-13 | 2015-12-31 | 2015-12-31 |
| NCT01643408 | A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy | COMPLETED | PHASE2 | 2012-11 | 2013-12 | 2013-08 |
| NCT01681121 | A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy | COMPLETED | PHASE2 | 2012-09 | 2013-08 | 2013-08 |
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | COMPLETED | PHASE3 | 2012-06-29 | 2015-12-28 | 2015-07-10 |
| NCT01551524 | Phase I Study of mPEG-R-Crisantaspase Given IV | COMPLETED | PHASE1 | 2012-03 | 2015-02 | 2015-02 |
| NCT01964547 | A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients | COMPLETED | PHASE4 | 2012-01 | 2013-05 | 2013-05 |
| NCT01485770 | A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness | COMPLETED | PHASE2 | 2011-12 | 2012-05 | 2012-05 |
| NCT01461915 | Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients | TERMINATED | PHASE2 | 2011-11 | 2015-06 | 2012-12 |
| NCT01361607 | Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer | COMPLETED | PHASE3 | 2011-05-27 | 2014-11-24 | 2014-11-24 |
| NCT05391724 | Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects | COMPLETED | PHASE1 | 2011-02 | 2011-09 | 2011-09 |
| NCT01337089 | Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain | COMPLETED | PHASE3 | 2011-01-19 | 2016-01-27 | 2016-01-27 |
| NCT01143181 | Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses | COMPLETED | PHASE3 | 2010-12 | 2012-12 | 2012-12 |
| NCT01241344 | Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease | COMPLETED | PHASE2 | 2010-11 | 2013-06 | 2013-06 |
| NCT01217112 | GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes | COMPLETED | PHASE2 | 2010-10 | 2012-09 | 2012-05 |
| NCT01161641 | Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery | TERMINATED | PHASE1 | 2010-07 | 2012-02 | 2012-02 |
| NCT01080820 | A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers | COMPLETED | PHASE1 | 2010-06 | 2010-12 | 2010-12 |
| NCT00803023 | Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia | COMPLETED | PHASE3 | 2010-03 | | 2010-07 |
| NCT00793598 | CMX001 in Post-transplant Patients With BK Virus Viruria | COMPLETED | PHASE1, PHASE2 | 2009-11 | 2010-10 | 2010-10 |
| NCT00942305 | Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients | COMPLETED | PHASE2 | 2009-10 | 2012-01 | 2012-01 |
| NCT00901732 | Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | UNKNOWN | PHASE1, PHASE2 | 2009-05 | 2010-11 | 2010-11 |
| NCT00822094 | Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML) | COMPLETED | PHASE2 | 2009-02 | 2012-01 | 2011-12 |
| NCT00788892 | Trial of CPX-351 in Newly Diagnosed Elderly AML Patients | COMPLETED | PHASE2 | 2008-10 | 2011-12 | 2010-06 |
| NCT00780182 | Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers | COMPLETED | PHASE1 | 2008-10 | 2009-01 | 2008-12 |
| NCT00670696 | A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel | WITHDRAWN | PHASE4 | 2008-04 | | 2008-12 |
| NCT01323569 | Abuse Potential of Sativex | COMPLETED | PHASE1 | 2008-02 | 2008-06 | 2008-06 |
| NCT01323465 | Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex | COMPLETED | PHASE1 | 2008-02 | 2008-03 | 2008-03 |
| NCT00681538 | A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) | COMPLETED | PHASE3 | 2008-01 | 2009-01 | 2009-01 |
| NCT01322464 | Study to Assess Food Effect on Sativex Bioavailability | COMPLETED | PHASE1 | 2008-01 | 2008-02 | 2008-02 |
| NCT01322139 | Sativex Thorough QT/QTc Study | COMPLETED | PHASE1 | 2007-12 | 2008-06 | 2008-06 |
| NCT00628498 | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study | COMPLETED | PHASE3 | 2007-12 | 2016-09 | 2016-07 |
| NCT00594945 | Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures | COMPLETED | PHASE2 | 2007-12 | 2009-06 | 2008-12 |
| NCT00598078 | Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor | COMPLETED | PHASE2 | 2007-12 | 2008-12 | 2008-08 |
| NCT00702468 | Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis | COMPLETED | PHASE3 | 2007-11 | 2009-01 | 2009-01 |
| NCT00457951 | A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD | TERMINATED | PHASE2 | 2007-04 | 2009-10 | 2009-08 |
| NCT00713817 | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain | COMPLETED | PHASE3 | 2007-03 | 2007-07 | 2007-07 |
| NCT00423605 | Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. | COMPLETED | PHASE3 | 2006-12 | 2010-01 | 2010-01 |
| NCT00423813 | A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. | COMPLETED | PHASE3 | 2006-12 | 2009-06 | 2009-04 |
| NCT00389428 | Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer. | COMPLETED | PHASE1 | 2006-09 | 2009-12 | 2008-12 |
| NCT00371137 | A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia | COMPLETED | PHASE3 | 2006-08 | 2008-12 | 2008-09 |
| NCT00361842 | Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer | COMPLETED | PHASE2 | 2006-07 | 2008-12 | 2008-12 |
| NCT00358501 | Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients | COMPLETED | PHASE3 | 2006-07 | 2015-03 | 2008-09 |
| NCT00713323 | A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. | COMPLETED | PHASE3 | 2005-10 | 2007-06 | 2007-06 |
| NCT00710554 | A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia | COMPLETED | PHASE3 | 2005-08 | 2006-10 | 2006-10 |
| NCT00710424 | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy | COMPLETED | PHASE3 | 2005-07 | 2006-06 | 2006-06 |
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | COMPLETED | PHASE3 | 2005-03 | 2005-12 | 2005-12 |
| NCT00106860 | A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder | COMPLETED | PHASE3 | 2005-03 | 2006-03 | |
| NCT00097708 | Experimental Medication For the Treatment of Generalized Anxiety Disorder | COMPLETED | PHASE3 | 2004-11 | 2005-12 | |
| NCT00132873 | Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy | COMPLETED | PHASE3 | 2004-10 | 2007-12 | 2007-09 |
| NCT00087555 | Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia | COMPLETED | PHASE2 | 2004-07 | 2006-01 | 2005-04 |
| NCT00086281 | Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients | COMPLETED | PHASE4 | 2003-11 | 2005-11 | 2005-06 |
| NCT00066170 | Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy | COMPLETED | PHASE3 | 2003-04 | 2004-11 | 2004-07 |
| NCT00678795 | A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis | COMPLETED | PHASE3 | 2002-08 | 2005-10 | 2005-10 |
| NCT01606202 | A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury | COMPLETED | PHASE3 | 2002-07 | 2005-01 | 2005-01 |
| NCT00711646 | A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. | COMPLETED | PHASE3 | 2002-06 | 2004-03 | 2004-03 |
| NCT00711880 | A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. | COMPLETED | PHASE3 | 2002-05 | 2004-03 | 2004-03 |
| NCT00675948 | Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain | COMPLETED | PHASE3 | 2002-04 | 2006-09 | 2006-09 |
| NCT01604265 | A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis | COMPLETED | PHASE3 | 2002-03 | 2002-08 | 2002-08 |
| NCT01606176 | A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin | COMPLETED | PHASE3 | 2002-03 | 2002-08 | 2002-08 |
| NCT00674609 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy | COMPLETED | PHASE3 | 2002-02 | 2004-03 | 2004-02 |
| NCT01606137 | A Study of the Long-term Safety of Sativex Use | COMPLETED | PHASE3 | 2002-02 | 2004-12 | 2004-12 |
| NCT01606189 | A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain | COMPLETED | PHASE3 | 2001-12 | 2002-09 | 2002-09 |
| NCT01610687 | A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis | COMPLETED | PHASE3 | 2001-07 | 2005-02 | 2005-02 |
| NCT01610700 | An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients | COMPLETED | PHASE3 | 2001-05 | 2002-07 | 2002-07 |
| NCT01610713 | An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis | COMPLETED | PHASE3 | 2001-05 | 2002-07 | 2002-07 |